[IKT] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -35.02%
YoY-
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/03/18 31/03/17 CAGR
Revenue 271 240 124 167 591 691 247 3.13%
PBT -547 -430 -1,212 -2,344 -1,736 -125 -186 43.22%
Tax -540 -422 -1,205 -2,339 -1,733 -12 -6 347.52%
NP -547 -430 -1,212 -2,344 -1,736 -125 -186 43.22%
Tax Rate - - - - - - - -
Total Cost 818 670 1,337 2,511 2,327 816 433 23.59%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -202.17 -178.97 -974.37 -1,404.30 -293.75 -18.08 -75.05 39.09%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.40 -0.32 -0.89 -1.72 -1.27 -0.10 -0.14 41.85%
EPS Diluted -0.40 -0.32 -0.89 -1.72 -1.27 -0.10 -0.14 41.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.